BACKGROUND: Conflicting data exist on the effects of GH replacement therapy (GHRT) on thyroid function and thyroid volume (TV) in GH-deficient (GHD) patients. AIM: The aim of this study was to assess the effects of GHRT on thyroid function and TV in adults with congenital lifetime isolated GHD (IGHD). SUBJECTS AND METHODS: We studied 20 GH-naïve adults with IGHD due to a homozygous mutation of the GHRH-receptor gene at baseline, after 6-month depot- GH replacement therapy (pGH), and 6-month washout (6mo). Total T(3), free T(4) (FT(4)), reverse T(3) (rT(3)), TSH, IGF-I, SHBG, and TV were measured; body surface area-corrected TV (CTV) was calculated. RESULTS: IGF-I and T(3) increased pGH. T(3) levels remained elevated at 6mo. GHRT did not significantly change FT(4), rT(3), TSH, and SHBG. TV and CTV increased pGH and remained elevated at 6mo. CONCLUSIONS: GHRT in IGHD adults caused an increase in serum T(3) levels and TV, suggesting an important role of the GH-IGF-I axis in thyroid function.
BACKGROUND: Conflicting data exist on the effects of GH replacement therapy (GHRT) on thyroid function and thyroid volume (TV) in GH-deficient (GHD) patients. AIM: The aim of this study was to assess the effects of GHRT on thyroid function and TV in adults with congenital lifetime isolated GHD (IGHD). SUBJECTS AND METHODS: We studied 20 GH-naïve adults with IGHD due to a homozygous mutation of the GHRH-receptor gene at baseline, after 6-month depot- GH replacement therapy (pGH), and 6-month washout (6mo). Total T(3), free T(4) (FT(4)), reverse T(3) (rT(3)), TSH, IGF-I, SHBG, and TV were measured; body surface area-corrected TV (CTV) was calculated. RESULTS:IGF-I and T(3) increased pGH. T(3) levels remained elevated at 6mo. GHRT did not significantly change FT(4), rT(3), TSH, and SHBG. TV and CTV increased pGH and remained elevated at 6mo. CONCLUSIONS: GHRT in IGHD adults caused an increase in serum T(3) levels and TV, suggesting an important role of the GH-IGF-I axis in thyroid function.
Authors: Marta Regina Silva Alcântara; Roberto Salvatori; Paula Regina Silva Alcântara; Luciana Michele A Nóbrega; Vera Simone Campos; Elma Cristina O Oliveira; Marcelo Henrique S Oliveira; Anita Hermínia Oliveira Souza; Manuel Hermínio Aguiar-Oliveira Journal: J Clin Endocrinol Metab Date: 2006-01-04 Impact factor: 5.958
Authors: R Salvatori; C Y Hayashida; M H Aguiar-Oliveira; J A Phillips; A H Souza; R G Gondo; S P Toledo; M M Conceicão; M Prince; H G Maheshwari; G Baumann; M A Levine Journal: J Clin Endocrinol Metab Date: 1999-03 Impact factor: 5.958
Authors: M A Hussain; O Schmitz; J O Jorgensen; J S Christiansen; J Weeke; C Schmid; E R Froesch Journal: Eur J Endocrinol Date: 1996-05 Impact factor: 6.664
Authors: Joselina L M Oliveira; Manuel H Aguiar-Oliveira; Argemiro D'Oliveira; Rossana M C Pereira; Carla R P Oliveira; Catarine T Farias; José A Barreto-Filho; Fernando D Anjos-Andrade; Celi Marques-Santos; Adão C Nascimento-Junior; Erica O Alves; Francielle T Oliveira; Viviane C Campos; Roberto Ximenes; Amanda Blackford; Giovanni Parmigiani; Roberto Salvatori Journal: J Clin Endocrinol Metab Date: 2007-10-02 Impact factor: 5.958
Authors: P Sgrò; M Sansone; A Parisi; A Sartorio; A Sansone; F Romanelli; A Lenzi; L Di Luigi Journal: J Endocrinol Invest Date: 2016-05-26 Impact factor: 4.256